The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at...
New data from 100,438 patients with Boston Scientific implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds...
St. Jude Medical Inc. has received CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...
Wearable cardioverter defibrillators (WCD) can be an effective therapy option for patients with a transient or undefined arrhythmic risk, according to the WEARIT-II Registry, the largest...
Biotronik announced the U.S. Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D...
The Population Health Research Institute (PHRI) has conducted a further independent analysis of data received from ongoing prospective registries that monitor the performance of the St. Jude...
Tyrx Inc. has received a license from Health Canada to market its new AigisRx R Fully Resorbable Antibacterial Envelope technology with implantable electronic devices (IEDs). The AigisRx R...
Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D...
The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty societies, released appropriate use criteria for implantable cardioverter-defibrillators (ICDs)...
Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D...
Oklahoma Heart Hospital (OHH), Oklahoma’s first dedicated heart hospital, has excelled at creating quality outcomes through an integrated approach to patient care. To...
New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat...
The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX system. The device is a first-in-class implantable cardiac defibrillator (ICD...
In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD...
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology and trends. With collaboration from my Editorial Advisory Board, we developed a...
The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN). The secure, Internet-based remote care system is for...
August 20, 2012 — Zoll Medical Corp., a manufacturer of medical devices and related software solutions, announced that physicians at all of the 17 “Honor Roll” hospitals and all of the 50 “Best...
St. Jude Medical Inc. (announced European CE mark approval of the Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds)....
The U.S. Food and Drug Administration (FDA) in October granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world’s first commercially available subcutaneous ...
November 12, 2012 — Boston Scientific Corp. and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce...
More than 350,000 deaths occur each year as a result of sudden cardiac arrest (SCA), which occurs when the heart abruptly and unexpectedly stops beating. A survey issued by the Heart Rhythm...
October 12, 2012 — Biotronik announced the start of the prospective multicenter PARCADIA study. The study aims to identify risk factors that can help predict appropriate ICD...
TyRx Inc. announced that it has received a license from Health Canada to market its AigisRx Antibacterial Envelope. The AigisRx Envelope is specifically designed to stabilize...
September 11, 2012 — St. Jude Medical Inc. announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and the...
August 30, 2012 — Implantable devices for treating cardiac arrhythmias, which include implantable cardioverter defibrillators (ICDs), are already underused in parts of Eastern and Central...
August 21, 2012 — Zoll Medical Corp. entered into an agreement to license Inovise Medical Inc.’s ambulatory Audicor technology as part of the advanced patient diagnostics in the LifeVest...
August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable...
In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care....
July 23, 2012 — Biotronik announced that the first CRT-D patient has been enrolled in the Biotronik EuroEco Trial — the European Health Economic Trial on Home Monitoring in...
July 11, 2012 — Biotronik, a manufacturer of innovative medical technology, announced that enrollment is now complete for the much anticipated SPIRIT-...
Boston Scientific Corporation has closed its acquisition of Cameron Health and, as a result, added to its product portfolio the world's first and only commercially available subcutaneous...
June 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved revised product labeling for Boston Scientific Corp.’s Incepta, Energen, Punctua, Cognis and Teligen...
Current risk stratification paradigms for sudden cardiac arrest (SCA) are designed to identify high‐risk populations based primarily on assessment of left ventricular ejection fraction (LVEF)....
The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...
Initial results from the international Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS (EFFORTLESS) subcutaneous implantable defibrillator (S-ICD Registry shows that the...
A study of more than 350 competitive athletes with implantable cardioverter defibrillators (ICDs) from around the world showed for the first time that sports may be safer for this...
May 1, 2012 — Cameron Health Inc. announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel voted 7-1 that sufficient data exists demonstrating the efficacy and...
April 15, 2012 - St. Jude Medical Inc., a global medical device company, announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more...
The cost to place an implantable cardioverter-defibrillator (ICD) increased by $844 per case after a new requirement from the Centers for Medicare and Medicaid Services (CMS) went into effect in...
March 19, 2012 - Cameron Health Inc. announced today that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel will review the premarket approval (PMA) application of the S...
January 31, 2012 — Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with...
December 23, 2011 — Biotronik announced the first implantations of the new Lumax 740 implantable cardiac defibrillators — the world’s first and only ICDs eligible for use with magnetic resonance...
December 16, 2011 – St. Jude Medical began a voluntary recall Nov. 28 for its Riata and Riata ST Silicone Defibrillation Leads, which the U.S. Food and Drug Administration (FDA) has now classified...
December 6, 2011 — Boston Scientific Corp. announced U.S. Food and Drug Administration (FDA) approval of its Incepta, Energen and Punctua cardiac resynchronization therapy defibrillators (CRT-Ds)...
November 16, 2011 — MedSolutions announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program. The system uses evidence-based guidelines to ensure the...
September 12, 2011 — Cardiovascular market research firm Zacks Equity Research released a new report discussing high growth areas in medical devices, including Medtronic Inc., Boston Scientific...
September 1, 2011 – St. Jude Medical Inc. announced the first insertion of an implantable cardioverter defibrillator (ICD) as part of a United States clinical study. The trial will examine the...
Canada is spearheading an international study to determine if an implantable cardioverter defibrillator (ICD) can prevent death from serious heart rhythm problems in those patients who’ve survived...
May 10, 2011 – The world's smallest and thinnest high-energy cardiac resynchronization therapy defibrillators (CRT-Ds) and implantable cardioverter defibrillators (ICDs) to treat heart failure and...
May 6, 2011 – New data presented at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions are the first to look at the use of highly specialized signals within...
May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to...
March 4, 2011 – According to a retrospective sub-study of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), there is no evidence that implantable cardioverter defibrillator (ICD) benefit...
March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to...
February 1, 2011 – Despite the benefits of therapy with implantable cardioverter-defibrillators (ICDs), inappropriate shocks from the devices are common and place patients at a greater mortality...
January 28, 2011 – The Civil Division of the U.S. Department of Justice (DOJ) filed a civil False Claims Act lawsuit against Boston Scientific, Guidant LLC and other entities seeking additional...
January 24, 2011 – Boston Scientific has reached an agreement with Fukuda Denshi to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan. Fukuda Denshi will...
December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific...
October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to evaluate the Tyrx AigisRx Antibacterial Envelope. The device is designed to help...
October 20, 2010 – New study results show that patients undergoing cardiac implantable electronic device (CIED) implantation had a 99.5 percent rate of successful implantation with an overall...
October 5, 2010 – Data from a prospective study show physicians may benefit from knowing complication rates associated with pacemaker or implantable cardioverter defibrillator (ICD) generator...
October 4, 2010 – Long-term data from a clinical trial studying the benefits of implantable cardioverter defibrillator (ICD) therapy have been published in Circulation.
September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD),...
September 8, 2010 – Total complications for new implantable cardioverter defibrillator (ICD) implants (including death in the laboratory) have decreased from 3.77 percent in 2006 to 2.87 percent...
August 12, 2010 - Chicago’s Northwestern Memorial Hospital heart rhythm specialists recently gave a 34-year-old man an implantable cardioverter defibrillator (ICD) that did not require X-ray...
July 27, 2010 – Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based,...
July 20, 2010 – The final results of the landmark TRUST Trial (Lumax-T/Lumos-T Safely RedUceS RouTine Office Device Follow-up), which show wireless remote monitoring of implantable cardiac devices...
July 13, 2010 – A new meta-analysis of five implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of sudden cardiac death (SCD) on overall mortality in women.
July 8, 2010 – A new consensus statement released recently by the Heart Rhythm Society (HRS) offers guidance for managing cardiovascular implantable electronic devices (CIEDs) in patients nearing...
